Jamaican Scientists on Verge of Creating Cannabis-Based Hepatitis C Drugs

Dr. Wayne McLaughlin

Research scientists, led by Dr. Henry Lowe, say they have discovered properties in cannabidiol, one of the major bioactive compounds in the cannabis plant, that have the potential to provide affordable treatment as nutraceuticals and pharmaceuticals for hepatitis C.

In vitro studies to demonstrate the antiviral activity of cannabidiol against HCV, Lowe and his research team — Jamaican Wayne McLaughlin and Cameroonian Dr. Ngeh Toyang — state in their published study, adding that cannabidiol was shown to have activity against HCV in vitro but not against hepatitis B virus (HBV).

On Friday, Lowe, who is known worldwide for his anti-cancer and ganja research, as well as the production of a range of nutraceuticals using Jamaican plants, told the Jamaica Observer that the discovery is a major development.

“This is a new discovery which has fantastic potential for the

... read more at: http://atlantablackstar.com/2017/02/17/jamaican-scientists-close-creating-drugs-hepatitis-c-cannabis-ganja-plant/